These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23138905)

  • 21. Combined fertility and embryotoxicity study.
    Reynaud L; Marsden E
    Methods Mol Biol; 2013; 947():125-37. PubMed ID: 23138901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developmental toxicity testing of biopharmaceuticals in nonhuman primates: previous experience and future directions.
    Martin PL; Weinbauer GF
    Int J Toxicol; 2010 Dec; 29(6):552-68. PubMed ID: 20926830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre- and postnatal developmental toxicity study design for pharmaceuticals.
    Bailey GP; Wise LD; Buschmann J; Hurtt M; Fisher JE
    Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):437-45. PubMed ID: 20025040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Considerations in assessing the developmental and reproductive toxicity potential of biopharmaceuticals.
    Martin PL; Breslin W; Rocca M; Wright D; Cavagnaro J
    Birth Defects Res B Dev Reprod Toxicol; 2009 Jun; 86(3):176-203. PubMed ID: 19462404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teratology studies in the rat.
    Leroy M; Allais L
    Methods Mol Biol; 2013; 947():95-109. PubMed ID: 23138899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of ixekizumab, an interleukin-17A monoclonal antibody, for potential effects on reproduction and development, including immune system function, in cynomolgus monkeys.
    Clarke DO; Hilbish KG; Waters DG; Newcomb DL; Chellman GJ
    Reprod Toxicol; 2015 Dec; 58():160-73. PubMed ID: 26482726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotoxicity testing in nonhuman primates.
    Grote-Wessels S; Frings W; Smith CA; Weinbauer GF
    Methods Mol Biol; 2010; 598():341-59. PubMed ID: 19967524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developmental immunotoxicity (DIT) testing of pharmaceuticals: current practices, state of the science, knowledge gaps, and recommendations.
    Collinge M; Burns-Naas LA; Chellman GJ; Kawabata TT; Komocsar WJ; Piccotti JR; Shenton J; Wierda D
    J Immunotoxicol; 2012; 9(2):210-30. PubMed ID: 22428536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developmental and peri-postnatal study in cynomolgus monkeys with belimumab, a monoclonal antibody directed against B-lymphocyte stimulator.
    Auyeung-Kim DJ; Devalaraja MN; Migone TS; Cai W; Chellman GJ
    Reprod Toxicol; 2009 Dec; 28(4):443-55. PubMed ID: 19631735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Teratology studies in the rabbit.
    Allais L; Reynaud L
    Methods Mol Biol; 2013; 947():139-56. PubMed ID: 23138902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Embryo-fetal developmental toxicity study design for pharmaceuticals.
    Wise LD; Buschmann J; Feuston MH; Fisher JE; Hew KW; Hoberman AM; Lerman SA; Ooshima Y; Stump DG
    Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):418-28. PubMed ID: 20025038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of prenatal growth and development in the crab-eating macaque (Macaca fascicularis) by ultrasound.
    Tarantal AF; Hendrickx AG
    Anat Rec; 1988 Oct; 222(2):177-84. PubMed ID: 3063137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental toxicity assessment of tanezumab, an anti-nerve growth factor monoclonal antibody, in cynomolgus monkeys (Macaca fascicularis).
    Bowman CJ; Evans M; Cummings T; Oneda S; Butt M; Hurst S; Gremminger JL; Shelton D; Kamperschroer C; Zorbas M
    Reprod Toxicol; 2015 Jun; 53():105-18. PubMed ID: 25461901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ductus venosus and intrahepatic venous system in Callithrix jacchus jacchus and Macaca fascicularis fetuses.
    Tchirikov M; Schlabritz-Loutsevitch NE; Hubbard GB; Tardif S; Schröder HJ; Nathanielsz PW
    J Med Primatol; 2006 Feb; 35(1):18-24. PubMed ID: 16430491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practical aspects of including functional endpoints in developmental toxicity studies. Case study: immune function in HuCD4 transgenic mice exposed to anti-CD4 MAb in utero.
    Herzyk DJ; Bugelski PJ; Hart TK; Wier PJ
    Hum Exp Toxicol; 2002; 21(9-10):507-12. PubMed ID: 12458908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reproductive toxicity of denosumab in cynomolgus monkeys.
    Bussiere JL; Pyrah I; Boyce R; Branstetter D; Loomis M; Andrews-Cleavenger D; Farman C; Elliott G; Chellman G
    Reprod Toxicol; 2013 Dec; 42():27-40. PubMed ID: 23886817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of ICOS+ T cell depletion via afucosylated monoclonal antibody MEDI-570 on pregnant cynomolgus monkeys and the developing offspring.
    Nicholson SM; Carlesso G; Cheng LI; Cook H; DaCosta K; Leininger J; McKeever K; Scott SW; Taylor D; Streicher K; Eck S; Reed M; Faggioni R; Herbst R; Dixit R; Ryan PC
    Reprod Toxicol; 2017 Dec; 74():116-133. PubMed ID: 28916434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Teratogenicity of all-trans retinoic acid during early embryonic development in the cynomolgus monkey (Macaca fascicularis).
    Hendrickx AG; Hummler H
    Teratology; 1992 Jan; 45(1):65-74. PubMed ID: 1731397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The nonclinical fertility study design for pharmaceuticals.
    Lerman SA; Hew KW; Stewart J; Stump DG; Wise LD
    Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):429-36. PubMed ID: 20025039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of an anti-TNF-alpha monoclonal antibody, administered throughout pregnancy and lactation, on the development of the macaque immune system.
    Martin PL; Oneda S; Treacy G
    Am J Reprod Immunol; 2007 Aug; 58(2):138-49. PubMed ID: 17631007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.